Stockrabit · Analysts
Questions across 2 calls

Rahul Jeewani

IIFL Capital Services

Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited CC-Jun25.pdf · 2025-08-07
So the EBITDA losses which we indicated from these new hospitals in 2Q, that number, I think, would be closer to INR20 crores to INR25 crores for 2Q. So can you also quantify the combined losses which we had from these new hospitals in 1Q, just so that we better understand in terms of how these losses are moving from 1Q to 2Q?
Dr. Abhinay, you said that Nashik ramp-up obviously has been slow, so because of insurance delays. So when do you expect these insurance contracts to get formed up in Nashik? Because I think Nashik, we commissioned last year in September. So yes, apparently…
Krishna Institute of Medical Sciences Limited CC-Mar25.pdf · 2025-05-13
Sir, just a clarification. The new units, you said had an INR18 crores EBITDA loss. That, I think, is the number for the full year and not the quarter.
Okay. Sure, Dr. Abhinay. And Dr. Abhinay, how do you look at this drag from the new units going into FY '26 So obviously, Thane and the 2 Bangalore hospitals would increase the drag here. So do you think that this INR18 crores kind of a loss which we booked this year can inch up to a INR40 crores, INR50 crores kind of a number going into '26? And then if you can also comment on the trajectory of these new hospitals by FY '27?